Back to Journals » Degenerative Neurological and Neuromuscular Disease
Degenerative Neurological and Neuromuscular Disease
Editor-in-Chief: Professor Thomas Müller
An international, peer-reviewed, open access journal focusing on research into the biological and clinical basis of degenerative neurological diseases including Multiple Sclerosis, Huntington’s disease, Alzheimer’s Disease, Parkinson’s Disease and Friedreich’s ataxia.
Specific topics covered in the journal include:
- Natural history, epidemiology, detection and screening
- Pathophysiology, causative agents and vectors, cellular research and biomarkers
- Identification of biotargets and agents with novel mechanisms of action
- Optimal clinical use of existing agents, including combination therapies
- Complementary and alternative medicine
- Palliative care
- Patient adherence, quality of life, satisfaction
- Health economic evaluations
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
This journal offers Accelerated Publication.
Articles:
- View all (150)
- Volume 16, 2026 (6)
- Volume 15, 2025 (9)
- Volume 14, 2024 (11)
- Volume 13, 2023 (10)
- Volume 12, 2022 (11)
- Volume 11, 2021 (6)
- Volume 10, 2020 (4)
- Volume 9, 2019 (11)
- Volume 8, 2018 (8)
- Volume 7, 2017 (10)
- Volume 6, 2016 (11)
- Volume 5, 2015 (12)
- Volume 4, 2014 (13)
- Volume 3, 2013 (8)
- Volume 2, 2012 (14)
- Volume 1, 2011 (6)
Latest articles:
- 5 records -
Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda
Nassanga R, Kaddumukasa M, Jones SE, Sajatovic M, Nemani A, Basiimwa RC, Kawooya MG, Tumwine JK, Lwere K, Gumikiriza-Onoria JL, Mubuuke AG, Nakasujja N
Degenerative Neurological and Neuromuscular Disease 2026, 16:590989
Published Date: 30 April 2026
The Gut-Brain Axis in Alzheimer’s: From Microbiota Genetics to Stigmasterol’s Neuroprotection Mechanism
Ding T, Chen J, Xiang Y, Zhou X, Zheng H, Bai Y, Wang W, Fu Q, Chen Y, Fu Y
Degenerative Neurological and Neuromuscular Disease 2026, 16:580890
Published Date: 27 April 2026
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program
Carotenuto A, Naoumis D, Brescia Morra V, Kouremenos E, Hetherington S, Arnould S, Heras VDL
Degenerative Neurological and Neuromuscular Disease 2026, 16:540207
Published Date: 15 April 2026
Emodin, a Phytotherapeutic Anthraquinone, Potently Attenuates Synaptic Redox Pathology in Aged Rats
Saha P, Ahmad F
Degenerative Neurological and Neuromuscular Disease 2026, 16:570320
Published Date: 20 February 2026
Genetic Spectrum and Phenotypic Variability in Chinese Patients with Multisystem Proteinopathy and Related Disorders
Xia X, Chen X, Sun Y, Zhang M, Qiao K, Chen Y, Zhao C, Dong Y, Zhu W
Degenerative Neurological and Neuromuscular Disease 2026, 16:568971
Published Date: 18 February 2026
